ABOUT THIS FUND
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
PRICE
$105.92 ▼ DOWN 2.56% (−$2.79)HOLDINGS
TOP 20 OF 64 · 38.54% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
